KALVISTA PHARMACEUTICALS INC. news, videos and press releases
For more news please use our advanced search feature.
KALVISTA PHARMACEUTICALS INC. - More news...
KALVISTA PHARMACEUTICALS INC. - More news...
- KalVista Pharmaceuticals Appoints Laurence Reid, Ph.D., to Board of Directors
- KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Nicole Sweeny as Chief Commercial Officer
- KalVista Pharmaceuticals Presents New HAE Attack Journey Data at 2023 US HAEA National Summit
- KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 US HAEA National Summit
- KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KalVista Pharmaceuticals to Present Data at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology (EAACI)
- KalVista Pharmaceuticals to Present at Jefferies Global Healthcare Conference
- KalVista Pharmaceuticals to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day Virtual Conference
- KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KalVista Pharmaceuticals to Present Data at the 13th C1-inhibitor Deficiency & Angioedema Workshop
- KalVista Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference
- KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
- KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
- KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology
- KalVista Pharmaceuticals Provides Progress Updates on Sebetralstat Development
- KalVista Pharmaceuticals Announces Publication of Sebetralstat Phase 2 Data in The Lancet
- KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session
- KalVista Pharmaceuticals to Present at SVB Securities Global Biopharma Conference
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KalVista Pharmaceuticals Announces Benjamin L. Palleiko Promoted to President
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KalVista Pharmaceuticals Announces $58 Million Registered Direct Offering
- KalVista Pharmaceuticals Reports Second Fiscal Quarter Results
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
